UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 24,
Mustang Bio (NASDAQ:MBIO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Mustang Bio Charts.
Mustang Bio (NASDAQ:MBIO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Mustang Bio Charts.

Mustang Bio, Inc. News

Mustang Bio Announces Closing of $4 Million Public Offering
Friday 3 May 2024 (6 days ago) • GlobeNewswire Inc.
Mustang Bio Announces Pricing of $4 Million Public Offering
Tuesday 30 April 2024 (1 week ago) • GlobeNewswire Inc.
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Friday 29 March 2024 (1 month ago) • GlobeNewswire Inc.
Form 8-K - Current report
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 26 January 2024 (3 months ago) • Edgar (US Regulatory)
Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
Friday 12 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Friday 5 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Wednesday 20 December 2023 (5 months ago) • Edgar (US Regulatory)

More Mustang Bio, Inc. News Articles